What's breaking now, across thousands of outlets.
Samsung Biologics Co. is seeking to raise about 3 trillion won ($2.2 billion) in a rights offering to fund its acquisition of PolyPeptide Group.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
(RTTNews) - The Indonesia stock market on Thursday wrote a finish to the two-day slide in which it had given up more than 120 points or 1.9 percent.
From a major Ather investment and Lenskart’s block deal to fresh orders for Tejas Networks, NBCC and Skipper, several stocks are in focus today.
The provincial government released its first quarter financial update with a deficit at $825 million, slightly worse than the $819 million projected when the budget was released.
India’s venture narrative is undergoing a fundamental evolution. We are transitioning from a nation that built digital software for the world to one that engineers frontier hardware and deep tech for…
